Clare Cutland
Overview
Explore the profile of Clare Cutland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
2217
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goncalves B, Lykke M, Cutland C, Horvath-Puho E, Bijlsma M, Procter S
Int J Epidemiol
. 2025 Feb;
54(1).
PMID: 39903877
No abstract available.
2.
Kwatra G, Izu A, Cutland C, Akaba G, Ali M, Ahmed Z, et al.
Lancet Microbe
. 2024 Aug;
5(10):100897.
PMID: 39178870
Background: Rectovaginal group B Streptococcus (GBS) colonisation in pregnant individuals at the time of labour is a major risk factor for invasive GBS disease by age 7 days (early-onset disease)....
3.
Mentzer A, Dilthey A, Pollard M, Gurdasani D, Karakoc E, Carstensen T, et al.
Nat Med
. 2024 May;
30(5):1384-1394.
PMID: 38740997
How human genetic variation contributes to vaccine effectiveness in infants is unclear, and data are limited on these relationships in populations with African ancestries. We undertook genetic analyses of vaccine...
4.
Schwalbe N, Nunes M, Cutland C, Wahl B, Reidpath D
J Urban Health
. 2024 Apr;
101(5):923-933.
PMID: 38578336
This study reviews the impact of eligibility policies in the early rollout of the COVID-19 vaccine on coverage and probable outcomes, with a focus on New York City. We conducted...
5.
Muthoni J, Otwombe K, Thaele D, Choge I, Steenberg B, Cutland C, et al.
Vaccines (Basel)
. 2023 May;
11(5).
PMID: 37243064
In combatting COronaVIrus Disease 2019 (COVID-19), immunization is the most prominent strategy. However, vaccination hesitancy-meaning delays in accepting or denying inoculation regardless of availability-has been identified as an essential threat...
6.
Smith M, Kwatra G, Izu A, Nel A, Cutland C, Ahmed K, et al.
Viruses
. 2023 Feb;
15(2).
PMID: 36851662
Vaccines against SARS-CoV-2 have been pivotal in overcoming the COVID-19 pandemic yet understanding the subsequent outcomes and immunological effects remain crucial, especially for at-risk groups e.g., people living with human...
7.
Hooli S, King C, McCollum E, Colbourn T, Lufesi N, Mwansambo C, et al.
Int J Infect Dis
. 2023 Feb;
129:240-250.
PMID: 36805325
Objectives: We determined the pulse oximetry benefit in pediatric pneumonia mortality risk stratification and chest-indrawing pneumonia in-hospital mortality risk factors. Methods: We report the characteristics and in-hospital pneumonia-related mortality of...
8.
Martin H, Falconer J, Addo-Yobo E, Aneja S, Arroyo L, Asghar R, et al.
J Glob Health
. 2022 Dec;
12:04075.
PMID: 36579417
Background: The existing World Health Organization (WHO) pneumonia case management guidelines rely on clinical symptoms and signs for identifying, classifying, and treating pneumonia in children up to 5 years old....
9.
Feldman C, Dlamini S, Richards G, Black J, Butler I, Cutland C, et al.
J Thorac Dis
. 2022 Nov;
14(10):4150-4172.
PMID: 36389298
Pneumococcal infections remain a common global cause of significant morbidity and mortality. The first recommendations for adult pneumococcal vaccination, published in South Africa in 1999, contained information only on the...
10.
Sikhosana M, Suchard M, Kuonza L, Cutland C, Slogrove A, Otwombe K, et al.
AJOG Glob Rep
. 2022 Oct;
2(3):100056.
PMID: 36276804
Background: Preeclampsia is a considerable cause of maternal and infant morbidity and mortality. Although its etiology is unknown, preeclampsia has been described as a state of exaggerated maternal inflammatory response....